Germany, May 11 -- Germany based Viatris Healthcare GmbH, kohlpharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient pyridostigmine (excluding retarded Dafo), ATC N07AA02 for the period 01012025 - 31122026. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....